IP in India: beyond the headlines
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

IP in India: beyond the headlines

The debate over pharmaceutical patents and how they relate to the public interest draws a lot of attention, but IP in India is much more than that - as our India IP & Innovation Forum later this month will show

India has captured headlines around the world for its controversial approach to patents, especially those relating to medicines. For rights holders and patent practitioners, the topic has immediate practical ramifications: Will my patent be subjected to a compulsory licence? What can I do to meet the various requirements that are unique to India, such as section 8 reporting requirements or the higher obviousness standard articulated by the IP Appellate Board?


Prabha Sridevan, former chairperson of the IPAB

This topic will play a central role at Managing IP’s India IP & Innovation Forum on February 26 in New Delhi. Our keynote speaker will be Prabha Sridevan, former chairperson of the IPAB, which is arguably the most important, and certainly the most active, body deciding intellectual property disputes in India. During her tenure at the IPAB, she played a leading role in these discussions. Not only did she affirm the compulsory licence granted for Bayer’s Nexavar cancer drug, but she also handed down important guidance on a wide range of topics, from the issue of standing for challenging a patent to the duties of the patent office in evaluating section 8 challenges.

Chairperson Sridevan will be joining us at the Forum to discuss these issues and how these topics affect not only practitioners but also civil society and its stake in the system. Speakers from a wide range of perspectives will offer their views, including representatives from the India Patent Office, Novartis and the Organisation of Pharmaceutical Producers of India.

Of course, India has a lot more going on than just pharmaceutical patents. Practitioners, academics and in-house counsel will also be providing updates and insights into a wide range of topics that rights holders have to be aware of. Speakers from the patent agents association and Samsung as well as well-respected practitioners will discuss the role of utility model patents in India, and how companies can best take advantage of the so-called baby patent. Another panel of practitioners, academics and in-house counsel will discuss licensing issues and how to take advantage of open innovation to promote innovation.

These are just some of the topics we will be covering at the India IP & Innovation Forum. The event will be free for in-house counsel and academics, and we hope you can join and share with us your views on what IP practitioners need to be aware of in India.

Click here to register for the India IP & Innovation Forum.

more from across site and ros bottom lb

More from across our site

Managing IP reveals Tuesday’s highlights, including an illuminating discussion celebrating women in the workplace and the challenges that remain
Dana Northcott, INTA’s 2024 president and associate general counsel for Amazon's IP team, talks about her work for the association
Managing IP reveals highlights from the INTA Annual Meeting, including law firms’ diversity and ESG concerns and a new beginning for a Chinese firm
Firms with a broad geographic reach are more likely to win work, especially from global companies with high turnovers, according to survey data of nearly 29,000 corporate counsel
IP STARS, Managing IP’s accreditation title, reveals its latest rankings for trademark work today, including which firms are on the up
Highlights from Sunday included judicial insight from across the globe and a keynote address from Martin Luther King Jr’s daughter
Managing IP’s senior reporter Rani Mehta interviewed attendees at the INTA Annual Meeting in Atlanta about how they made the most out of their first day
A team of lawyers who joined Norton Rose Fulbright from Polsinelli say they were drawn to the firm's global platform
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Lawyers say a ruling concerning liability for trademark infringement could give company directors an easy way out and create litigation uncertainty
Gift this article